Research shows that pfizer (PFE.US) Ibrance is expected to treat appendiceal cancer.
Pfizer's breast cancer drug Ibrance has shown promising effects in treating a certain type of appendiceal cancer.
Pfizer's Ibrance Shows Promise in Treating Appendix Cancer: Study
Lilly, Gilead, Amgen Started at Outperform by Bernstein
Pfizer Options Spot-On: On October 16th, 86,372 Contracts Were Traded, With 3 Million Open Interest
On October 16th ET, $Pfizer(PFE.US)$ had active options trading, with a total trading volume of 86,372 options for the day, of which put options accounted for 26.51% of the total transactions, and
ViiV Reports Positive Real-world Data for HIV Prevention Drug
Novavax Stock Plummets as FDA Pauses Clinical Trial on Safety Concerns -- Barrons.com